Mark Ebadi, MD
NPI 1639140247 · Specialist · Denver, CO
Enrolled with Medicare as Practitioner - Allergy/Immunology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Ebadi, MD is a Specialist provider in Denver, CO (NPI 1639140247).
Provider details
- NPI number
- 1639140247
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 40389 (CO)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
11,083 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Professional Service for Preparation and Provision of 1 Or More Antigens95165 | 5,907 | $15 |
| Test for Allergy Using Allergenic Extract95004 | 3,227 | $4 |
| Professional Service for Multiple Injections of Allergen95117 | 502 | $12 |
| Professional Service for Single Injection of Allergen95115 | 422 | $10 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 346 | $126 |
| Test for Allergy Using Allergenic Extract Injected Into Skin95024 | 207 | $8 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ipratropium Bromide | 402 | 110 |
| Budesonide/Formoterol Fumaratebrand: Symbicort | 186 | 39 |
| Fluticasone Propion/Salmeterolbrand: Advair Hfa | 183 | 40 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 143 | 67 |
| Montelukast Sodium | 140 | 35 |
| Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol | 103 | 31 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$243 across 11 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-31
- Last updated
- 2007-12-19
Frequently asked questions
- What is Mark Ebadi's NPI number?
- Mark Ebadi's National Provider Identifier (NPI) is 1639140247, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Ebadi's specialty?
- Mark Ebadi is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Mark Ebadi located?
- Mark Ebadi's practice location on file with NPPES is 125 Rampart Way, Denver, CO 80230-6406.
- What is Mark Ebadi's phone number?
- The practice phone number listed in the NPPES registry for Mark Ebadi is (720) 858-7600.
- Does Mark Ebadi accept Medicare?
- Mark Ebadi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Ebadi's NPI active?
- Yes — Mark Ebadi's NPI (1639140247) is active in the NPPES registry as of the last update on 2007-12-19.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.